Pharmaceutical quality. Built on evidence.Remote services available worldwide
SERVICE 05

Sterile Manufacturing & Contamination Control Consulting

Sterile manufacturing consulting from Pune, with remote support worldwide for contamination-control documentation, qualification evidence, cleanrooms, critical utilities and monitoring systems.

Vials beneath automated filling equipment
Quality by design · Evidence by practice
WHEN CLIENTS ENGAGE US

Sterile-manufacturing support when contamination risk needs stronger control.

Engagements may begin during Annex 1 remediation, facility change, aseptic-process improvement, qualification activity or investigation of recurring environmental, utility or contamination-control concerns.

01

Annex 1 & CCS remediation

Assess contamination-control gaps, strengthen CCS structure and connect identified risks with supporting controls, evidence and action plans.

02

New or modified sterile facilities

Support cleanroom, HVAC, personnel/material flow, utility and equipment readiness where sterile operations are being introduced or changed.

03

Aseptic process & APS readiness

Strengthen APS/media-fill documentation, intervention rationale, execution readiness, deviation handling and supporting evidence.

04

EM, cleanroom & utility concerns

Review monitoring, qualification and trend evidence where excursions, recurring events or control weaknesses require structured assessment.

WHAT WE CAN SUPPORT

Sterile operations built around contamination control.

Support is tailored to your site, system, product context, risk profile and internal quality procedures.

Sterile manufacturing control depends on the interaction between facility design, people, processes, utilities, environmental monitoring, qualification and operational discipline. These elements need to function as one integrated contamination-control system.

We support assessment, documentation and qualification activities that connect contamination risks to preventive controls, objective evidence and continued verification across the sterile-manufacturing lifecycle.

01

Contamination Control Strategy (CCS) Support

Support development and review of CCS elements, interfaces, supporting evidence and action tracking.

02

EU GMP Annex 1 Readiness

Gap assessment and readiness support against Annex 1 expectations for sterile operations and contamination control.

03

Cleanroom & HVAC Qualification

Qualification support for classification, airflow, HEPA integrity, pressure cascades, recovery and environmental conditions.

04

Aseptic Process Simulation Documentation Support

Protocol, report and evidence support for APS/media-fill design, execution, interventions, deviations and review.

05

Sterilisation & Depyrogenation System Readiness

Readiness and qualification support for sterilizers, depyrogenation tunnels, cycles, loads and critical parameters.

06

Environmental Monitoring Programme Review

Review of EM strategy, locations, frequencies, limits, trends, investigations and linkage to contamination-control principles.

07

Cleanroom Zoning & Personnel/Material Flow Review

Review zoning, personnel and material flows, transfer controls and contamination risks across sterile areas.

08

Sterile Utility Assessment & Action Tracking

Assessment and action tracking for critical sterile utilities, process gases and associated monitoring or control systems.

CONTAMINATION-CONTROL LIFECYCLE

From contamination risk to continued state of control.

Annex 1 places contamination control at the centre of sterile manufacturing. Our approach connects risk assessment, facility and process controls, qualification, APS, monitoring and continued verification.

01

Map contamination risk

Identify contamination pathways, critical process steps, personnel and material interfaces, utilities, interventions and environmental risks.

02

Structure the CCS

Connect contamination risks with preventive and detective controls, responsibilities, supporting evidence and improvement actions.

03

Control facility & flow

Review cleanroom zoning, HVAC performance, pressure relationships, personnel/material movement and transfer controls.

04

Qualify systems & utilities

Support qualification and evidence review for cleanrooms, HVAC, sterilisation systems, depyrogenation equipment and critical utilities.

05

Challenge the aseptic process

Support APS/media-fill strategy, intervention assessment, execution documentation, deviations and evaluation of aseptic-process performance.

06

Monitor & verify

Use environmental, utility, process and qualification evidence to identify trends, investigate loss of control and support continued verification.

STERILE-MANUFACTURING EVIDENCE

Controls that work together to protect the sterile process.

Deliverables are tailored to facility design, process risk, product, lifecycle stage, client procedures and applicable sterile-manufacturing requirements.

TYPICAL DELIVERABLES

Contamination-control & sterile support

  • CCS assessment, structure and improvement support
  • EU GMP Annex 1 readiness assessments
  • Cleanroom and HVAC qualification documentation
  • Aseptic Process Simulation / media-fill documentation support
  • Environmental-monitoring programme review
  • Personnel and material-flow assessments
  • Sterilisation and depyrogenation readiness support
  • Critical sterile-utility assessment and action tracking
REFERENCE FRAMEWORKS

Sterile-control principles

  • EU GMP Annex 1 — Manufacture of Sterile Medicinal Products
  • EU GMP Annex 15 — Qualification & Validation
  • ICH Q9(R1) — Quality Risk Management
  • ISO 14644 cleanroom classification principles, where applicable
  • Applicable GMP requirements for sterile manufacture
  • Client Contamination Control Strategy and Pharmaceutical Quality System
CLIENT OUTCOME

A defensible contamination-control state

A sterile-manufacturing system in which contamination risks are understood, critical controls are supported by objective evidence and monitoring, qualification and operational practices remain connected through the CCS.

Risk → Controls → Evidence → Verification
PROJECT QUESTIONS

Scoping sterile-manufacturing support.

What can be reviewed before a facility visit?

A remote review may cover the contamination-control strategy, facility information, relevant procedures, monitoring trends and qualification summaries supplied under the agreed scope. The review should identify questions that need direct observation or further evidence.

Can a document review establish how an aseptic process performs?

A document review has defined limits. Activities such as observing personnel practices, assessing interventions or reviewing physical airflow conditions may require suitable site-based assessment and evidence. The engagement should state those limits clearly.

What should we include in an initial enquiry?

Describe the product and presentation at a high level, whether processing is aseptic or terminally sterilised, the project stage and the main concern. Include the facility location and timeline so the remote and any on-site scope can be assessed.

Explore worldwide service coverage
LET'S DISCUSS YOUR NEEDS

Need support with Sterile Manufacturing?

Tell us your context and what outcome you need to achieve.

Discuss a project ↗
QUALITY & COMPLIANCE

Compliance-minded. Evidence-led.

Work is scoped against applicable client procedures, regulatory requirements and guidance. Depending on the engagement, reference frameworks may include GxP, FDA 21 CFR requirements, EU GMP Annexes 1, 11 & 15, ICH Q9(R1), and ISO 9001:2015 quality-management principles.

◎Remote services available worldwidePune, Maharashtra, India